![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HIV-1 Attachment Inhibitor Prodrug BMS-663068
in Antiretroviral-Experienced Subjects:
Analysis of Emergent Viral Drug Resistance Through 48 Weeks of Follow-Up
|
|
|
Reported by Jules Levin
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 2015 July 19-23
M Lataillade,N Zhou,1 SR Joshi,1 S Lee,1 D Stock,1 GJ Hanna,2 M Krystal1
Bristol-Myers Squibb, 1Wallingford, CT and 2Princeton, NJ, USA
![IAS1.gif](../images/072415/072415-9/IAS1.gif)
![IAS2.gif](../images/072415/072415-9/IAS2.gif)
![IAS3.gif](../images/072415/072415-9/IAS3.gif)
![IAS4.gif](../images/072415/072415-9/IAS4.gif)
![IAS5.gif](../images/072415/072415-9/IAS5.gif)
![IAS6.gif](../images/072415/072415-9/IAS6.gif)
![IAS7.gif](../images/072415/072415-9/IAS7.gif)
![IAS8.gif](../images/072415/072415-9/IAS8.gif)
![IAS9.gif](../images/072415/072415-9/IAS9.gif)
![IAS10.gif](../images/072415/072415-9/IAS10.gif)
![IAS11.gif](../images/072415/072415-9/IAS11.gif)
![IAS12.gif](../images/072415/072415-9/IAS12.gif)
![IAS13.gif](../images/072415/072415-9/IAS13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|